NLY-01 is a peptide and a GLP-1 agonist, specifically a pegylated exenatide. Pegylation increases the stability and half-life of the drug in the body, allowing for sustained activity.
NLY-01 is being developed to slow the progression of Parkinson's by providing neuroprotective benefits and reducing inflammation.
Science-based supplements that work synergistically
Subscribe & Join Our Pre-Order Waitlist
We are providing people with Parkinson’s disease, or who are at risk of getting Parkinson’s disease, with the best tips, tools and insights to prevent or mitigate their disease.
This site does not provide medical advice, diagnosis, or treatment. Before implementing any lifestyle or health change, first consult with a qualified health care professional.
Your cart is currently empty.
Start Shopping
